Back to today’s briefing

Story perspectives

Stanford Study: New Inhibitor Restores Neuron Function in Parkinson's

7/5/2025

40 5

Summary

Story summary

A groundbreaking Stanford Medicine study reveals that blocking the overactive LRRK2 enzyme can save neurons in mice with a genetic mutation tied to Parkinson's disease. The MLi-2 inhibitor not only restored vital primary cilia but also enhanced communication between dopamine neurons and the striatum. Researchers are now eager to explore this treatment's potential for other forms of Parkinson's.

1 of 1

Story summary

A groundbreaking Stanford Medicine study reveals that blocking the overactive LRRK2 enzyme can save neurons in mice with a genetic mutation tied to Parkinson's disease. The MLi-2 inhibitor not only restored vital primary cilia but also enhanced communication between dopamine neurons and the striatum. Researchers are now eager to explore this treatment's potential for other forms of Parkinson's.